In This Article:
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.
Top 5 Upgrades:
-
HSBC upgraded Keurig Dr Pepper (KDP) to Buy from Hold with a price target of $42, up from $36. With Q1 net sales growth of 6% and comparable EPS up 10%, the company "managed to build some cushion for holding on to its full-year guidance," says the firm, which sees the company being "in the right place with the right brands."
-
KeyBanc upgraded Lowe's (LOW) to Overweight from Sector Weight with a $266 price target. The firm sees a buying opportunity for "patient investors" into this "high-quality businesses" following the recent share pullback.
-
RBC Capital upgraded Procter & Gamble (PG) to Outperform from Sector Perform with a price target of $177, up from $164. The firm thinks investors should take advantage of Procter's share pullback, "especially in this market."
-
Northland upgraded SolarEdge (SEDG) to Market Perform from Underperform with a price target of $12.50, down from $15. Shares have declined significantly since the firm cut the stock to Underperform late in February, notes the firm, which estimates that SolarEdge will exit calendar year 2025 with about $350M in net cash and doesn't expect the company to file for bankruptcy.
-
Citi upgraded Hasbro (HAS) to Buy from Neutral with a $72 price target. The firm says Hasbro has been, by far, the biggest positive surprise of the post-Liberation Day environment to date.
Top 5 Downgrades:
-
RBC Capital downgraded Global Payments (GPN) to Sector Perform from Outperform with a price target of $86, down from $139, following a more detailed review of the Worldpay acquisition and sale of its Issuer business.
-
HSBC downgraded Align Technology (ALGN) to Hold from Buy with a price target of $170, down from $290. The firm adjusted ratings in medical technology and life sciences are quantifying the risk/reward using stagflation, weak macro environment, and recovery scenario analyses.
-
Roth Capital downgraded Canadian Solar (CSIQ) to Neutral from Buy with a price target of $9, down from $15. Over the past 18 months, Canadian Solar's core module business has been challenged given the global oversupply, the firm tells investors in a research note.
-
HSBC downgraded Iqvia (IQV) to Hold from Buy with a price target of $160, down from $260. HSBC's analysis of historical sector multiples reveals that the multiples compression might have an additional 20%-25% downside in a stagflation scenario
-
Canaccord downgraded ASGN (ASGN) to Hold from Buy with a price target of $55, down from $115. The company's Assignment revenue has yet to trough despite what has now been a couple of years since macro headwinds began to appear, the firm tells investors in a research note.